Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$268.26 - $339.48 $689,428 - $872,463
-2,570 Reduced 42.77%
3,439 $939,000
Q1 2024

May 02, 2024

SELL
$304.11 - $351.99 $71,769 - $83,069
-236 Reduced 3.78%
6,009 $2.08 Million
Q4 2023

Feb 14, 2024

BUY
$269.37 - $365.04 $959,495 - $1.3 Million
3,562 Added 132.76%
6,245 $2.02 Million
Q3 2023

Nov 13, 2023

SELL
$350.25 - $422.63 $473,538 - $571,395
-1,352 Reduced 33.51%
2,683 $961,000
Q2 2023

Aug 11, 2023

BUY
$359.49 - $486.4 $1.16 Million - $1.57 Million
3,226 Added 398.76%
4,035 $1.53 Million
Q1 2023

May 12, 2023

SELL
$418.69 - $503.0 $318,204 - $382,280
-760 Reduced 48.44%
809 $387,000
Q4 2022

Feb 08, 2023

BUY
$351.71 - $456.01 $140,684 - $182,404
400 Added 34.22%
1,569 $659,000
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $482,317 - $658,450
1,169 New
1,169 $488,000
Q2 2022

Aug 11, 2022

SELL
$463.67 - $597.16 $895,346 - $1.15 Million
-1,931 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$524.57 - $735.42 $1.01 Million - $1.42 Million
1,931 New
1,931 $1.12 Million
Q2 2021

Aug 16, 2021

SELL
$576.64 - $649.04 $196,057 - $220,673
-340 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$547.01 - $662.35 $185,983 - $225,199
340 New
340 $194 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.37B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.